Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma
Thomas Clozel(Owl Research Institute), Leandro Cerchietti(Cornell University), Ari Melnick(Cornell University), David W. Scott(BC Cancer Agency), Randy D. Gascoyne(BC Cancer Agency), John P. Leonard(New York University), Peter Martin(Northwestern University), Biljana Čuljković(Northwestern University), Micheal Leser(Northwestern University), Fabrizio Tabbò(Ospedale San Pietro Fatebenefratelli), Amy Chadburn(Cornell University), Lucy A. Godley(University of Chicago), Wayne Tam(Cornell University), Matthías Kormáksson(University of Iceland), Katherine L. B. Borden(Northwestern University), Rebecca Elstrom(Acentech (United States)), Rita Shaknovich(Medical Research Council), Aparna Vasanthakumar(University of Chicago), Sarah Wyman(Northwestern University), Giorgio Inghirami(Cornell University), ShaoNing Yang(Northwestern University), Samprit Banerjee(Northwestern University)
Cited by 216
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k